Reported to have an increase of 21% profit in Q2, this herbal company shows consistently good results. EPS keeps increasing YOY, and currently sits at 33. It is offering a dividend yield of 3.93%, and having PER 23.90x, PBV 7.59x, and ROE of 31.74%. It has relatively low DER of 13.53% with current ratio of 225%, quick ratio of 396.76%, and current ratio of 511.93%. This is a gem.
Technical analysis show the company's stock price has a major uptrend movement since 2018, which consists of consolidation and participation in the last two years. Based on the current rectangle chart pattern formed, it shows the uptrend will continue, and the price tends to move in the range of 695 - 815. If it manages to break the strong resistance at 815, will next target will be 930.
Cheers
Technical analysis show the company's stock price has a major uptrend movement since 2018, which consists of consolidation and participation in the last two years. Based on the current rectangle chart pattern formed, it shows the uptrend will continue, and the price tends to move in the range of 695 - 815. If it manages to break the strong resistance at 815, will next target will be 930.
Cheers